Early Addiction Care Pathway After Acute Drug Intoxication in Emergency Departments
NCT07738835 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266
Last updated 2026-07-31
Summary
Acute intoxication with psychoactive substances represents a major public health issue and a frequent reason for emergency department (ED) visits. Beyond the acute medical management of intoxication, one of the main challenges remains the continuity of addiction care after discharge. Many patients disengage rapidly from follow-up services, leading to recurrent intoxication episodes, repeated ED admissions, and increased morbidity.
The IPAIS study (Interventions Précoces en Addictologie dans le cadre des urgences par Intoxications aiguës aux Stupéfiants) is a multicenter, randomized, parallel-group, open-label clinical trial designed to evaluate whether an enhanced early addiction care pathway improves retention in addiction treatment among patients admitted to emergency departments for acute intoxication involving at least one illicit psychoactive substance (excluding isolated alcohol intoxication).
All participants will receive an early addiction consultation within 24 to 72 hours following the acute event. In the experimental group, this consultation will be combined with a structured and standardized feedback session on toxicological analysis results and a proactive follow-up strategy including scheduled telephone contacts over a 6-month period. The control group will receive early addiction consultation according to usual care procedures, without the structured feedback and standardized follow-up program implemented in the experimental arm.
The primary objective of the study is to determine whether the enhanced intervention improves retention in the addiction care pathway at 6 months after inclusion. Retention is defined as sustained engagement in addiction care, operationalized as at least one addiction-related consultation per month and/or regular telephone-based addiction follow-up over the 6-month period.
Conditions
- Intoxication; Opioid
Interventions
- BEHAVIORAL
-
Structured early addiction care
The intervention consists of a structured early addiction care program initiated during hospitalization for acute psychoactive substance intoxication. It includes: * A standardized addiction consultation during the index hospitalization; * A protocolized follow-up schedule over 6 months, with 1-2 structured contacts per month (in-person or telephone); * Systematic harm reduction assessment and counseling at predefined visits; * Collection and structured feedback of toxicological results (urine, blood, and hair samples), including discussion of discrepancies between declared and detected substance use; * Reinforcement of linkage to addiction services and maintenance in the care pathway. The intervention aims to enhance patient engagement, insight into substance use patterns, and long-term retention in addiction care.
- BEHAVIORAL
-
Not structured early addiction care
The intervention consists of a streamlined consultation with the implementation of addiction follow-up, possibly via video and telephone, and "treatment as usual" with routine toxicology tests typically used in most emergency departments. This program includes: * A standardized addiction consultation during initial hospitalization; * Addiction follow-up with random interviews and/or workshops, at least once a month, lasting 6 months or at the patient's request; * A systematic harm reduction assessment and support during pre-defined consultations, without taking into account the results of hair samples tests; * Collection of toxicology results (hair follicle), including a discussion of discrepancies between reported and detected substance use, at the end of the study at month 6.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
NGUYEN An Hung · Pitié Salpétrière
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-10-15
- Primary Completion
- 2029-10-15
- Completion
- 2030-04-15
Countries
- France
Study Locations
More Related Trials
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.
NCT01008072 ·Status: UNKNOWN
-
Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
NCT03489161 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Collaborative Care From the ED for Trauma Patients With Prescription Drug Misuse
NCT02804295 ·Status: COMPLETED ·Phase: NA
-
Examining Analgesic Synergy and Efficacy in Trauma Care
NCT07435077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
CEDRN: Opioid Registry
NCT07466784 ·Status: RECRUITING
-
Peer Intervention to Link Overdose Survivors to Treatment (PILOT)
NCT05123027 ·Status: COMPLETED ·Phase: NA
-
High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid
NCT03156907 ·Status: UNKNOWN ·Phase: PHASE2
-
Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center
NCT02245685 ·Status: COMPLETED
-
Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care
NCT01751789 ·Status: COMPLETED ·Phase: NA
-
The Emergency Department Longitudinal Integrated Care
NCT05327166 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
NCT05897788 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder
NCT03544112 ·Status: COMPLETED
-
Treatment of Polydrug-Using Opiate Dependents During Withdrawal
NCT00367874 ·Status: COMPLETED ·Phase: PHASE4
-
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
NCT01967641 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
NCT03337009 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
NCT00913770 ·Status: COMPLETED ·Phase: NA
-
Nasal Naloxone for Narcotic Overdose
NCT01912573 ·Status: UNKNOWN ·Phase: PHASE4
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
NCT07278518 ·Status: RECRUITING ·Phase: NA
-
Nalox-Comm: Naloxone Communication Training for Pharmacists
NCT04677387 ·Status: COMPLETED ·Phase: NA
-
Emergency Department Longitudinal Integrated Care
NCT03699085 ·Status: COMPLETED ·Phase: NA
-
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794 ·Status: COMPLETED ·Phase: NA
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA